Robust medical: by the end of October, 1159400 shares had been repurchased
Cailian news agency, Nov. 1, according to the prudent medical announcement, as of October 31, 2021, the company has repurchased 115942 shares of the company by means of centralized bidding transaction through the repurchase special securities account, accounting for 0.2719% of the total share capital of the company. The highest transaction price is 82.42 yuan / share, the lowest transaction price is 73.91 yuan / share, and the total transaction amount is 89.6513 million yuan (excluding transaction costs).
This text is a result of machine translation.
Related companies：
Briefing Yesterday 08:05 PM
· Healthcare
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Consumer Staples, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing Updated 6 hours ago
· Healthcare
Mozambique has reported polio cases for the first time in 30 years
Briefing Updated 4 hours ago
· Healthcare
The Spanish Ministry of health has confirmed that 7 suspected cases of monkeypox have tested positive
Briefing Jan 14, 2022 01:18 PM
· Healthcare
Mask protection unit rose in the afternoon
Healthcare
Nucleic Acid Drug CDMO Olipharma Raises Tens of Mns of CNY in Pre-Series A Round
As a new way to treat diseases, gene therapy has higher R&D investment and risk than biochemical drugs. Both pharmaceutical giants and start-ups tend to collaborate with outsourcing service providers, which brings business opportunities to cell and gene therapy contract development and manufacturing organizations (CDMOs).
Yesterday 09:59 PM
Briefing Jan 05, 2022 09:49 PM
· Healthcare
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Financials, Healthcare
Cell Therapy Developer Senlang Bio Raises CNY 200 Million in New Funding Round
Founded in 2016, Hebei Senlang Bio is a clinical-stage biotechnology company dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers.
Yesterday 01:00 PM
Briefing Aug 03, 2021 02:55 PM
· Healthcare
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Briefing Jul 22, 2021 07:33 PM
· Healthcare
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow
See more
Read next
In-depth
In-depth
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.